English
Arabic
Français
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Réunionnais
India
Noukoz
BabaShopCenter
Vidéo conférence
Runsound music
Films partner IMDb
Affiliation
Prêts Immobiliers
Beyond Tissue Samples: The Promise of Liquid Biopsy Market in Precision Medicine
The liquid biopsy market was estimated at USD 2.83 billion in 2022 and is likely to grow at a CAGR of 17.99% during 2023-2028 to reach USD 7.64 billion in 2028.
A liquid biopsy is a minimally invasive medical procedure that involves analyzing a blood sample or other bodily fluids to detect and monitor various diseases, including cancer.
Read More: https://www.globenewswire.com/en/news-release/2022/10/06/2529163/0/en/Liquid-Biopsy-Market-is-Projected-to-Reach-US-7-64-Billion-in-2028.html
The liquid biopsy market was estimated at USD 2.83 billion in 2022 and is likely to grow at a CAGR of 17.99% during 2023-2028 to reach USD 7.64 billion in 2028.
A liquid biopsy is a minimally invasive medical procedure that involves analyzing a blood sample or other bodily fluids to detect and monitor various diseases, including cancer.
Read More: https://www.globenewswire.com/en/news-release/2022/10/06/2529163/0/en/Liquid-Biopsy-Market-is-Projected-to-Reach-US-7-64-Billion-in-2028.html
Beyond Tissue Samples: The Promise of Liquid Biopsy Market in Precision Medicine
The liquid biopsy market was estimated at USD 2.83 billion in 2022 and is likely to grow at a CAGR of 17.99% during 2023-2028 to reach USD 7.64 billion in 2028.
A liquid biopsy is a minimally invasive medical procedure that involves analyzing a blood sample or other bodily fluids to detect and monitor various diseases, including cancer.
Read More: https://www.globenewswire.com/en/news-release/2022/10/06/2529163/0/en/Liquid-Biopsy-Market-is-Projected-to-Reach-US-7-64-Billion-in-2028.html
·523 Views
·0 Anteprima